Clondalkin Group has appointed David Lennon as Global CEO of the international packaging group’s Pharmaceutical and Healthcare Division.
Lennon will spearhead the roll-out of Clondalkin’s global business development plans working with the European and North American management teams.
Having joined Clondalkin in 2009 as CEO of the European Pharma and Healthcare division, Lennon was responsible for the expansion of accredited pharmaceutical packaging facilities from three to eight sites through organic development and strategic acquisition.
Commenting on the appointment, Clondalkin Group Chief Executive, Norbert McDermott, said: ‘We appointed David in 2009 because his pedigree as a senior executive as well as his packaging business expertise was clear. In his four years with Clondalkin Group he has continued to prove himself to be an invaluable leader in consolidating our position as a leading producer of secondary pharmaceutical packaging where we now operate from 18 sites in North America and Europe.’
